Amphotret (Amphotericin B for Injection U.S.P.) should be administered primarily to patients with progressive, potentially life-threatening fungal infections. Amphotret (Amphotericin B for Injection U.S.P.) should not be administered to treat non-invasive fungal infections such as oral thrush, vaginal candidiasis and oesophageal candidiasis in patients having normal neutrophil counts. Amphotret (Amphotericin B for Injection U.S.P.) is specifically indicated in the treatment of fungal infections susceptible to Amphotericin B such as the one caused by Candida spp., Aspergillus spp., Crytococcus neoformans, Mucor spp., Rhodotorula spp., Absidia spp., Blastomyces dermatitidis.
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
